by CyberKnife Miami | Jun 26, 2023 | Cancer Treatment, CyberKnife Center of Miami, CyberKnife Miami, CyberKnife News
While the CyberKnife robotic system was FDA approved for the treatment of tumors and nerve disorders in 2001 and has successfully treated hundreds of thousands of patients in America and worldwide for more than two decades, surprisingly many people still do not know...
by CyberKnife Miami | May 8, 2022 | Best Cancer Doctors, Best CyberKnife Doctors, CyberKnife News
Congratulations to Rich Strike for winning the Kentucky Derby. It was a great race. Cyberknife did the best he could today and he’ll be back. Most important, this racehorse helped educate the world about a life saving, noninvasive cancer treatment and that’s an...
by CyberKnife Miami | Apr 27, 2022 | Cancer Treatment, CyberKnife News, CyberKnife Treatment, Noninvasive Cancer Treatment
When it comes to horse racing, sometimes the long shot wins. That is what happened in the Arkansas Derby in April with a horse named, Cyberknife. The Short Story about the Long Shot The three-year-old colt won the race by 2 ¾ lengths. His odds were 8-to-1. And yet...
by CyberKnife Miami | Apr 15, 2022 | CyberKnife News
Cyberknife won the $1.25 million Arkansas Derby by 2 3/4 lengths in the richest prep race for the Kentucky Derby. Ridden by Florent Geroux, who got dumped in the post parade, Cyberknife ran 1 1/8 miles in 1:50.42. The 3-year-old colt earned 100 qualifying points for...
by CyberKnife Miami | Mar 17, 2022 | CyberKnife News
Just for fun we couldn’t pass up posting this story that’s getting a lot of media attention around the world. It turns out famous horse trainer, owner and racer, Brad Cox is entering his horse Cyberknife in the Arkansas Derby. So you know who all of us at...
by CyberKnife Miami | Nov 10, 2020 | Acoustic Neuromas, Best CyberKnife Doctors, Brain Tumor Treatment, CyberKnife Center of Miami, CyberKnife News
1 Single CyberKnife Treatment Proves Highly Effective for Acoustic Neuromas and Should Be Considered a Primary Treatment Option According to a Long Term Study. Radiation Oncologist Dr. Mark Pomper explains to Health Specialist Marilyn Mitzel why it’s superior to...
